|
[1]中华医学会传染病与寄生虫病学分会, 肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.
|
|
[2]中华医学会肝病学分会重型肝病与人工肝学组, 中华医学会感染病学分会肝衰竭与人工肝学组.肝衰竭诊疗指南[J].中华肝脏病杂志, 2006, 14 (9) :643-646.
|
|
[3]Sarin SK, Kumar A, Almeida JA, et al.Acute-on-chronicliver failure:consensus recommendations of the Asian PacificAssociation for the study of the liver (APASL) [J].HepatolInt, 2009, 3 (1) :269-282.
|
|
[4]Schi dt FV, Ostapowicz G, Murray N, et al.Alpha-feto-protein and prognosis in acute liver failure[J].Liver Transpl, 2006, 12 (12) :1776-1781.
|
|
[5]Selcuk H, Uruc I, Temel MA, et al.Factors prognostic of sur-vival in patients awaiting liver transplantation for end-stage liverdisease[J].Dig Dis Sci, 2007, 52 (11) :3217-3223.
|
|
[6]Macquillan GC, Seyam MS, Nightingale P, et al.Blood lac-tate but not serum phosphate levels can predict patient out-come in fulminant hepatic failure[J].Liver Transpl, 2005, 11 (9) :1073-1079.
|
|
[7]Bhatia V, Singh R, Acharya SK.Predictive value of arterialammonia for complications and outcome in acute liver failure[J].Gut, 2006, 55 (1) :98-104.
|
|
[8]Kumar R, Shalimar, Sharma H, et al.Prospective derivationand validation of early dynamic model for predicting outcomein patients with acute liver failure[J].Gut, 2012, 61 (7) :1068-1075.
|
|
[9]Naiki T, Nakayama N, Mochida S, et al.Novel scoring sys-tem as a useful model to predict the outcome of patientswith acute liver failure:Application to indication criteria for liv-er transplantation[J].Hepatol Res, 2012, 42 (1) :68-75.
|
|
[10]Chien RN, Lin CH, Liaw YF.The effect of lamivudine thera-py in hepatic decompensation during acute exacerbation ofchronic hepatitis B[J].J Hepatol, 2003, 38 (3) :322-327.
|
|
[11]Tsang SW, Chan HL, Leung NW, et al.Lamivudine treat-ment for fulminant hepatic failure due to acute exacerbationof chronic hepatitis B infection[J].Aliment Pharmacol Ther, 2001, 15 (11) :1737-1744.
|
|
[12]Yuen MF, Sablon E, Hui CK, et al.Prognostic factors in se-vere exacerbation of chronic hepatitis B[J].CID, 2003, 36 (8) :978-984.
|
|
[13]Tsubota A, Arase Y, Suzuki Y, et al.Lamivudine monotherapyfor spontaneous severe acute exacerbation of chronic hepatitisB[J].J Gastroenterol Hepatol, 2005, 20 (3) :426-432.
|
|
[14]陈禄彪, 曹红, 张宇锋, 等.抗病毒治疗对低病毒载量的乙肝ACLF患者生存率的影响[J].中华实验和临床病毒学杂志, 2010, 24 (5) :364-366.
|
|
[15]Cui YL, Yan F, Wang YB, et al.Nucleoside analogue canimprove the long-term prognosis of patients with hepatitisB virus infection associated acute on chronic liver failure[J].Dig Dis Sci, 2010, 55 (8) :2373-2380.
|
|
[16]Evenepoel P, Laleman W, Wilmer A, et al.Prometheus ver-sus molecular absorbents recirculating system:comparisonof efficiency in two different liver detoxification devices[J].Artif Organs, 2006, 30 (4) :276-284.
|
|
[17]Petersen BE.Hepatic stem cells:coming full circle[J].BloodCells Mol Dis, 2001, 27 (3) :590-600.
|
|
[18]Gilchrist ES, Plevris JN.Bone marrow-derived stem cells inliver repair:10 years down the line[J].Liver transpl, 2010, 16 (2) :118-129.
|
|
[19]Peng L, Xie DY, Lin BL, et al.Autologous bone marrowmesenchymal stem cell transplantation in liver failure patientscaused by hepatitis B:short-term and long-term out-comes[J].Hepatology, 2011, 54 (3) :820-828.
|
|
[20]杨文龙, 刘武, 李涛.小剂量糖皮质激素治疗早期重型肝炎临床疗效观察[J].国外医学 (流行病学传染病学分册) , 2005, 32 (5) :265-266.
|
|
[21]陈从新, 郭顺明, 刘波, 等.糖皮质激素阻断慢性乙型肝炎肝衰竭发生的临床对照观察[J].中华肝脏病杂志, 2003, 11 (1) :37-40.
|
|
[22]Matsumoto K, Miyake Y, Miyatake H.A combination treat-ment of entecavir and early-phase corticosteroid in severeexacerbation of chronic hepatitis B[J].World J Gastroen-terol, 2009, 15 (13) :1650-1652.
|
|
[23]甄秀梅, 罗光汉.糖皮质激素在乙型肝炎肝功能衰竭治疗中的应用[J].中华临床感染病杂志, 2010, 3 (2) :126-128.
|
|
[24]魏来, 陈知水.肝移植在肝衰竭治疗中的作用[J].内科急危重症杂志, 2009, 15 (3) :130-131.
|
DownLoad: